Acceleron Pharma

Employees:
120
Market Cap:
$1.23 billion
Revenue:
$27.89 million
5 Year Trend:
19.2%
Net Income:
$-67.17 million
NASDAQ:
XLRN

Acceleron Pharma, Inc. is a public American "clinical stage biopharmaceutical company" based in Boston, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-ß) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels. John Knopf, Jasbir Seehra, Tom Maniatis, Mark Ptashne and Wylie Vale formed the company in Cambridge, Massachusetts. Wikipedia

Acceleron Pharma
Employees:
120
Market Cap:
$1.23 billion
Revenue:
$27.89 million
5 Year Trend:
19.2%
Net Income:
$-67.17 million
NASDAQ:
XLRN

Acceleron Pharma, Inc. is a public American "clinical stage biopharmaceutical company" based in Boston, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-ß) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels. John Knopf, Jasbir Seehra, Tom Maniatis, Mark Ptashne and Wylie Vale formed the company in Cambridge, Massachusetts. Wikipedia

3 jobs at Acceleron Pharma

Jobs in